CG
ZVRA icon

Cutler Group’s Zevra Therapeutics ZVRA Stock Holding History

Cutler Group’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,500
Closed -$1K – 5641
2022
Q3 		$1K Hold
7,500
– – ﹤0.01% 4751
2022
Q2 		$2K Sell
7,500
-9,500
-56% -$43.3K ﹤0.01% 4408
2022
Q1 		$3K Buy
17,000
+8,000
+89% +$50.9K ﹤0.01% 4556
2021
Q4 		$13K Sell
9,000
-21,400
-70% -$191K ﹤0.01% 3506
2021
Q3 		$67K Sell
30,400
-5,700
-16% -$57.5K 0.01% 2269
2021
Q2 		$149K Buy
36,100
+20,000
+124% +$215K 0.01% 1555
2021
Q1 		$15K Buy
+16,100
New +$141K ﹤0.01% 3470

Other funds holding ZVRA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $246M AUM 27.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
MAM
Mystic Asset Management Warwick, Rhode Island $431M AUM 25.35% 1-Year Est. Return